---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "pzsI/pyBNgA3ObZWNtZmr82/u3b7j3OT59UedBxKIB/4hjEkp69e2mPk77G0660Adu+cbuyZiXR3e0TWxLhAVdbQMoR1cYEtDUzdssqVp1g/GONHoUTcueIfQNLVe0AhrylkxxMNWsUgSvSIHAjOVkGIPKSlwRLZEf+6MpEjJ3InJoHG5g+YlsR8OyWderFDPXmx+s9+iQsJ0Ffe4Ky8IY7oDOIAYObRyKQjVDSd273TkziI5Tjl2rapadOdQwEaxxmiPIUUw3dgyEt/U2to4/RZmFshmqrHJ6Hs4av2B4ovv44j+XCukrHFlU+6MRYvfTgz8z+3Cbs70tSJc6D+ZlyYhfTB8oTTX7+MQzTsWFE=;spvf5dd73b4GN208y97RyA=="
---

